REVERSE IMMUNIZATION
LIVE

Serial Number

90818040

Owner

CANOPY IMMUNO-THERAPEUTICS LTD.

Attorney

Alexander Lazouski

Filing Date

Jul 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

REVERSE IMMUNIZATION Trademark

Serial Number: 90818040 • Registration: 7295729

REVERSE IMMUNIZATION is a trademark filed by CANOPY IMMUNO-THERAPEUTICS LTD. on July 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CANOPY IMMUNO-THERAPEUTICS LTD. (3 trademarks)

Hagalim 5

Entity Type: 03

Trademark Details

Filing Date

July 8, 2021

Registration Date

January 30, 2024

Goods & Services

Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders; Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of recombinant proteins; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders by modulating the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the antibody creation and antigen specific immune response in autoimmune, Allergic and inflammatory diseases; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders by modulating the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen specific immune response in autoimmune, allergic and inflammatory diseases; Proteins including recombinant proteins pharmaceutical preparations and substances with potential immunomodulation activity to treat under and over responsiveness of the immune system

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 30, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jan 30, 2024 R.SR
ELECTRONIC RECORD REVIEW COMPLETE
Dec 28, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 22, 2023 ERRR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jul 3, 2023 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 25, 2023 ERFR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 23, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 23, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 23, 2023 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 23, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 23, 2023 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 14, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 14, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 15, 2023 GNFN
FINAL REFUSAL E-MAILED
Feb 15, 2023 GNFR
FINAL REFUSAL WRITTEN
Feb 15, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2022 CRFA
ASSIGNED TO LIE
Nov 10, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2021 NWOS
NEW APPLICATION ENTERED
Jul 12, 2021 NWAP